Hansa Biopharma AB (publ) (STO: HNSA)

Hansa Biopharma AB Revenue

Hansa Biopharma AB had revenue of 48.66M SEK in the quarter ending September 30, 2024, with 113.09% growth. This brings the company's revenue in the last twelve months to 189.39M, up 65.48% year-over-year. In the year 2023, Hansa Biopharma AB had annual revenue of 134.09M, down -13.22%.

• Revenue (ttm): 189.39M
• Revenue Growth: +65.48%
• P/S Ratio: 9.56
• Revenue / Employee: 1.40M
• Employees: 168
• Market Cap: 2.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	134.09M	-20.43M	-13.22%
Dec 31, 2022	154.53M	120.65M	356.12%
Dec 31, 2021	33.88M	27.78M	455.56%
Dec 31, 2020	6.10M	2.73M	81.27%
Dec 31, 2019	3.36M	6.00K	0.18%